hemovigilance

hemovigilance

(hē″mō-vij′ĭ-lăns) [ hemo- + vigilance]
Monitoring of possible adverse effects associated with blood transfusion therapy. It is directed at improving blood transfusion safety.
References in periodicals archive ?
Boosting blood safety surveillance in support of FDA efforts to further develop a national hemovigilance program;
The Centralized Hemovigilance Program improves the quality of the blood transfusion chain, primarily focusing on safety.
Blood banks should also participate in hemovigilance programs to ensure a certain standard of transfusion trends.
non-compliance with the fundamental legal principles of hemovigilance prescribed by the "Law on Transfusiology" [20].
Ten years of hemovigilance reports of transfusion related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.
7) Archived donor specimens are used principally for hemovigilance activities, including investigations of possible transfusion-transmitted infections and look-back testing.
FDA agreement to accept INTERCEPT platelet PMA based on existing portfolio of clinical and hemovigilance data.
Medical Center, the Netherlands) and Faber (Blood Transfusion Service, Red Cross, Luxembourg) compile 27 chapters by hematology, blood transfusion, and other specialists from Europe, North America, Asia, the Middle East, and Australia who outline safety procedures in the blood transfusion chain for those in the fields of transfusion medicine and quality and safety management, health and regulatory authorities, hospital transfusion committees, hemovigilance officers, personnel involved in the transfusion process, hospital managers, and students.
The Quebec hemovigilance system: description and results from the first two years.
The Hemovigilance Module added this year to the NHSN's Biovigilance Component [paragraph][paragraph] was designed specifically to bolster the collaborative capacity of public health and private industry to detect adverse events (e.
In order to assess the impact of their conversion to pathogen inactivated platelets, the blood centre performed a retrospective analysis of routinely collected active hemovigilance data collected both before and after the change.